Pfizer’s Post

5 points making BIG unique in breast cancer research 👇 1️⃣ Global collaboration: Uniting 10,000+ experts worldwide, BIG is the largest network dedicated to breast cancer research. 2️⃣ Direct impact: BIG focuses on developing better treatments and cures by conducting its own research. 3️⃣ Research integrity: BIG follows strict principles of research conduct, aiming to eliminate bias from the research process. 4️⃣ Speed and patient benefits: By engaging our network and sharing best practices, expertise, and data, we strive for faster results and greater benefits for patients. 5️⃣ Academic research: BIG collaborates with academic research groups exclusively dedicated to patient-centered breast cancer research. #BIGagainstbc #Breastcancer #Breastcancerresearch

In the latest episode of Targeted Talks, N. Arvind Dasari, MS, dives into the recent approval of fruquintinib for patients with metastatic colorectal cancer. #mCRC #crcsm | MD Anderson Cancer Center https://lnkd.in/eyphPCx7

🎙️ New CANCER BUZZ out now! In this episode, CANCER BUZZ speaks with Farrukh T. Awan, MD, MS, professor of Internal Medicine and director of Lymphoid Malignancies at the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, about their approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia. Watch: https://lnkd.in/e4i76VVQ. #Cancer #CancerCare #Oncology #Podcast

🎙️ New CANCER BUZZ out now! In this episode, CANCER BUZZ speaks with Farrukh T. Awan, MD, MS, professor of Internal Medicine and director of Lymphoid Malignancies at the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, about their approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia. Watch: https://lnkd.in/e4i76VVQ. #Cancer #CancerCare #Oncology #Podcast

Dive deep into the conference experience. The Cornerstone of Cancer Care and Research, takes a closer look at how interactions between clinicians and patients have changed over the years at 3rd Indian Cancer Congress 2023 Intriguing conversations and invaluable connections - the heart of every conference. Soaking in the knowledge and celebrating collaboration with American Society of Clinical Oncology (ASCO) #ConferenceMomentum Matthew Cowan | Eric Hamp 🎗️ #Oncology #Cancer #India #Community #ASCO #Healthcare #ClinicalTrial #Conference #ASCO23

I'm thrilled to share my latest research paper on the heterogeneity of the ER-/PR+ breast cancer subgroup. This study has sparked significant interest within the scientific community, and I'm grateful for the positive feedback it has received. We delved deep into understanding the unique characteristics of this breast cancer subtype, shedding light on potential treatment strategies. I believe this research holds great promise in improving patient outcomes. Please take a moment to read the paper and feel free to share your thoughts and insights. Together, we can make meaningful strides in the battle against breast cancer. #BreastCancerResearch #Oncology #MedicalScience https://lnkd.in/ezuHnp_S

Thanks for sharing your story Andrew Satterlee!

For the first time, you can hear the sound of a cancer cell dying. Recently, a team of researchers from Harvard Medical School isolated and recorded the sound of their destruction. This remarkable breakthrough aims to make the fight against cancer more tangible. In this interview, three members of the team share how the discovery came to be, inspired the entire #oncology community, and launched a new campaign by the American Society of Clinical Oncology (ASCO) and Health@WPP called "The Most Beautiful Sound." Hear the sound for yourself, and send this to someone you love who's fighting cancer: https://bit.ly/3To87sp #canceresearch #ConquerMag

On this World Neuroendocrine Tumor Awareness Day, take a moment to learn some important facts about NET Cancer. 🧡 Understanding this rare condition is crucial for everyone affected, including patients and their dedicated caregivers. Join us in raising awareness – share this post and help us support those battling NET Cancer. #netcancerawareness #ispiehealth #raleighnc

Hoag Family Cancer Institute is planning to launch a novel clinical trial for glioblastoma, a fast-forming and aggressive brain tumor. Dr. Simon Khagi, Medical Director of Neuro-Oncology at Hoag Family Cancer Institute, unveils the innovative approach of this upcoming trial aimed at combatting glioblastoma. Dive deeper into this groundbreaking research at hoag.org/brain-tumor. #BrainTumorAwarenessMonth #CancerCare #Glioblastoma